Aviana

Aviana Molecular Technologies (AMT) is a diagnostic company in the development stage, committed to innovating highly sensitive and user-friendly platform technologies, with its initial focus on developing point-of-care (POC) diagnostics for infections. AMT believes its technology can detect specific infections within 15 to 20 minutes and can be administered by healthcare professionals without laboratory training. This rapid and effective infection diagnosis can aid in the treatment and control of disease spread.